Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microfibril-associated protein 1 (MFAP1) is a spliceosome-associated protein involved in nuclear pre-mRNA splicing as part of the U2-type precatalytic spliceosome complex[2][7]. While originally named for its association with microfibrils in the extracellular matrix, subsequent studies have established its primary intracellular function as a scaffold facilitating the assembly and regulation of the spliceosome, aiding in alternative and constitutive splicing regulation[2][5][7]. It interacts directly with the Prp38 protein complex and contains highly conserved motifs involved in protein-protein interactions within the spliceosome[2][6]. MFAP1 expression is widespread across tissues and is considered essential for efficient mRNA splicing, but is not itself a therapeutic target such as a receptor, enzyme, or transporter[2][7]. Disease relevance is suggested by associations with conditions including juvenile glaucoma, but no direct involvement with drugs or known clinical biomarkers is reported[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microfibril-associated protein 1 (MFAP1).